Ibere Pharmaceuticals
(NYSE) IBER
Ibere Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$13.41M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
IBER News
IBER: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ibere Pharmaceuticals
Industry
Capital Markets
Sector
FinancialsEmployees
3
CEO
Osagie O. Imasogie
Website
www.iberepharma.comHeadquarters
Philadelphia, PA 19103, US
IBER Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
2%
Return on Capital
-1%
Return on Assets
1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.00M
Operating Income
$1.00M
EBITDA
$3.55M
Operating Cash Flow
$868.75K
Capital Expenditure
$0.00
Free Cash Flow
$868.75K
Cash & ST Invst.
$458.39K
Total Debt
$0.00
Ibere Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$234.00K
+25.7%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$1.81M
+4.7%
EBITDA
$234.00K
-113.5%
Quarterly Fundamentals
Net Cash
$154.41K
-122.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
1.13%
N/A
Return on Invested Capital
-0.73%
N/A
Free Cash Flow
$88.59K
+49.5%
Operating Cash Flow
$88.59K
+49.5%